Literature DB >> 1944238

Purification and characterization of human liver microsomal cytochrome P-450 2A6.

C H Yun1, T Shimada, F P Guengerich.   

Abstract

Cytochrome P-450 (P-450) 2A6 was purified by chromatography of human liver microsomes. The final preparation was electrophoretically homogeneous and contained 16 nmol of P-450/mg of protein. The amino-terminal amino acid sequence of the protein (first 13 residues) matched that of the reported cDNA exactly. The UV-visible spectrum indicated that the isolated hemoprotein was in the low-spin form. The protein was recognized by rabbit antibodies raised against rat P-450 2A1, and a rabbit antiserum against the P-450 2A6 preparation was also prepared. With these antibodies, it was estimated that P-450 2A6 accounted for a maximum of 1% of the total P-450 present in the human liver microsomes; the level varied greater than 100-fold among the 20 samples examined. Purified P-450 2A6 catalyzed coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation at rates similar to those measured in the human liver sample used to prepare P-450 2A6, and these two microsomal activities were strongly inhibited by the antibodies. The purified P-450 2A6 enzyme also catalyzed low levels of 4,4'-methylene-bis(2-chloroaniline) (MOCA) N-oxidation and activation of aflatoxin B1, 6-aminochrysene, 2-amino-3-methylimidazo[4,5-f]quinoline, and 2-amino-3,5-dimethylimidazo [4,5-f]quinoline to genotoxic products; the antibody inhibited the activity of purified P-450 2A6 towards aflatoxin B1 and 6-aminochrysene but did not inhibit these reactions in human liver microsomes (MOCA N-oxidation was inhibited approximately 20%). Human P-450 2A6 did not catalyze testosterone 7 alpha-hydroxylation, a characteristic activity of the related rat P-450 2A1 protein. These results emphasize the need to characterize individual P-450 enzymes in order to understand their functions in the context of more complex systems.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1944238

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  26 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

Review 3.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes.

Authors:  Tsutomu Shimada; Shigeo Takenaka; Norie Murayama; Hiroshi Yamazaki; Joo-Hwan Kim; Donghak Kim; Francis K Yoshimoto; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2015-02-16       Impact factor: 3.739

Review 5.  Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.

Authors:  T Yokoi; T Kamataki
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

6.  Binding free energies for nicotine analogs inhibiting cytochrome P450 2A6 by a combined use of molecular dynamics simulations and QM/MM-PBSA calculations.

Authors:  Haiting Lu; Xiaoqin Huang; Mohamed Diwan M AbdulHameed; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2014-03-03       Impact factor: 3.641

7.  Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.

Authors:  Medjda Bellamri; Lihua Yao; Radha Bonala; Francis Johnson; Linda B Von Weymarn; Robert J Turesky
Journal:  Arch Toxicol       Date:  2019-06-15       Impact factor: 5.153

8.  Toxicity of aflatoxin B1 to Helicoverpa zea and bioactivation by cytochrome P450 monooxygenases.

Authors:  Ren Sen Zeng; Ren Sen L Zeng; Guodong Niu; Zhimou Wen; Mary A Schuler; May R Berenbaum
Journal:  J Chem Ecol       Date:  2006-06-01       Impact factor: 2.626

9.  Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

Authors:  Yune-Fang Ueng; Chien-Chih Chen; Yu-Ting Chung; Tsung-Yun Liu; Yu-Ping Chang; Wei-Sheng Lo; Norie Murayama; Hiroshi Yamazaki; Pavel Souček; Gar-Yang Chau; Chin-Wen Chi; Ruei-Ming Chen; Ding-Tzai Li
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

10.  Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers.

Authors:  U Merkel; H Sigusch; A Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.